{{scheme.chgp}}%
{{scheme.chgp}}%
No Matches Found
{{scheme.chgp}}%
No Matches Found
No Matches Found
Silexion Therapeutics Corp. Stock Plummets to New 52-Week Low of $3.37
Silexion Therapeutics Corp. has reached a new 52-week low, reflecting significant volatility in the pharmaceuticals and biotechnology sector. With a market capitalization of USD 5 million, the company faces operational challenges, evidenced by a low return on equity and a lack of dividends, amid a contrasting performance compared to the S&P 500.
Silexion Therapeutics Corp. Stock Plummets to New 52-Week Low of $3.44
Silexion Therapeutics Corp. has reached a new 52-week low, reflecting a significant decline in its stock performance compared to the S&P 500. With a market capitalization of USD 5 million, the company faces challenges indicated by its high price-to-book ratio and negative return on equity, raising questions about its future strategies.
Silexion Therapeutics Corp. Stock Hits New 52-Week Low at $3.55
Silexion Therapeutics Corp. has reached a new 52-week low, emphasizing its stock volatility compared to a much higher peak. With a market capitalization of USD 5 million, the company faces financial challenges, including a negative return on equity and no dividend issuance, amid broader biotechnology sector trends.
{{list.post_title}}
{{list.post_excerpt}}
{{list.post_title}}
{{list.post_excerpt}}
